Cephalon, Inc.
<b>Corporate Headquarters</b>
41 Moores Road
Frazer
Pennsylvania
19355
United States
Tel: 610-344-0200
Fax: 610-344-0981
Website: http://www.cephalon.com/
302 articles about Cephalon, Inc.
-
Celyad is focusing on advancing chimeric antigen receptor T cell (CAR T) therapies.
-
Kaiser Sues Merck, Generic Drug Firm Over Millions in Losses Due to Alleged "Pay-for-Delay" Scheme
7/29/2021
Kaiser Permanente has reportedly filed a lawsuit against drug maker Merck for allegedly allowing a "pay-for-delay" scheme that cost the former millions of dollars. -
Movers and Shakers Oct. 1
10/1/2018
Here's a look at who shook things up in the world of pharma and biotech this week. -
The past few days has had a flurry of activity in the industry with leadership changes. Let's take a look at some of those!
-
Movers and Shakers for Sept. 10
9/10/2018
Let's take a look at who made a splash in the pharma and biotech world the past week. -
Synthorx Appoints Immuno-Oncology Veteran Joseph Leveque, M.D., as Chief Medical Officer
8/16/2018
Synthorx, Inc. today announced the appointment of Joseph Leveque, M.D., as chief medical officer.
-
European Commission (EC) Accuses Teva, Cephalon of Anti-Competitive Behavior
7/17/2017
-
Cephalon, U.S. States Reach $125 Million Settlement Over Generic Drugs
8/5/2016
-
Cephalon’s Narcolepsy Drug Modafinil May Be World’s First Safe ‘Smart Drug,’ Study Says
8/24/2015
-
FTC Settlement Of Cephalon, Inc. Pay For Delay Case Ensures $1.2 Billion In Ill-Gotten Gains Relinquished; Refunds Will Go To Purchasers Affected By Anticompetitive Tactics
5/28/2015
-
Teva Pharmaceutical Industries Limited's Cephalon, Inc. Accused of Fraud by Whistleblower
3/21/2013
-
Myriad Genetics, Inc. and Cephalon, Inc. Enter Into Companion Diagnostic Agreement
3/29/2012
-
Stemline Therapeutics, Inc. Appoints Kevin Buchi, Former CEO of Cephalon, Inc., to Its Board of Directors
3/15/2012
-
Cephalon, Inc. Drama Topped Several Major Health-Care Deals
3/2/2012
-
Teva Pharmaceutical Industries Limited's Cephalon, Inc. Recalls Treanda Leukemia Drug Due to Glass Fragments
1/31/2012
-
Teva Pharmaceutical Industries Limited Dismisses Media Reports of Layoff After Cephalon, Inc. Buyout
11/10/2011
-
Teva Pharmaceutical Industries Limited to Sack 1,500 Cephalon, Inc. Workers
11/9/2011
-
ImmuPharma plc Regains Lupuzor Rights from Cephalon, Inc. Due to Teva Pharmaceutical Industries Limited Merger
10/21/2011
-
Mesoblast Limited and Cephalon, Inc. Receives Deals of Distinction Award for Stem CellTherapeutics for Degenerative Conditions
10/20/2011
-
Acino Holding Ltd to Buy Cephalon, Inc. Units For EU 80 Million Cash, Shares
10/17/2011